[ad_1]
Kindbody introduced it had acquired Chicago-based surrogacy company Various Reproductive Assets, the most recent in a spate of offers by the hybrid fertility care and advantages firm this yr.
Kindbody stated the acquisition will deliver surrogacy providers in-house. ARR’s staff will work within the firm’s KindEOS division, which focuses on egg and embryo donation.
This marks the corporate’s third acquisition thus far in 2022. In February, Kindbody stated it had entered into an agreement to purchase Vios Fertility Institute, a series of fertility clinics. It additionally added in-house genetic testing with the acquisition of Phosphorus Labs earlier this summer season.
“The trail to parenthood with gestational surrogacy is advanced, costly, and might final many months and even years,” Greg Poulos, president of Kindbody, stated in an announcement. “By bringing gestational surrogacy in-house and integrating it with Kindbody’s care-delivery mannequin, we’ve the chance to dramatically enhance conception probabilities, decrease prices and assist our sufferers deliver residence a wholesome child as quickly as potential. I’m delighted to welcome the ARR crew to the Kindbody household and look ahead to having them be part of the KindEOS crew.”
THE LARGER TREND
Kindbody introduced $62 million Series C funding a couple of yr in the past and $32 million Series B financing in 2020. The fertility startup stated its complete increase is $154 million. The corporate has additionally been increasing its brick-and-mortar clinic footprint this yr and launched a line of home fertility hormone tests for men and women.
In the meantime, a rising variety of employers are providing fertility advantages to their staff. In line with a Mercer survey of employer-sponsored well being plans, solely 36% of corporations with 20,000 or extra staff provided in-vitro fertilization protection in 2015, in contrast with 42% in 2020.
One other startup within the area is fertility-benefits supervisor Carrot Fertility, which raised $75 million in Series C funding last year. Direct-to-consumer virtual-care firm Ro has additionally been delving deeper into fertility care with the acquisition of Dadi, a male-fertility-testing and sperm-testing startup. It had additionally purchased Modern Fertility in 2021. One other male-fertility startup, Legacy, scored $25 million in Could, and hybrid ladies’s well being supplier Tia recently expanded into fertility testing, counseling and care planning.
Different fertility corporations embrace Progyny, Proov and kegg.
[ad_2]
Source link